Advertisement

 

 

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
Author Information (click to view)

Punyawudho B, Singkham N, Thammajaruk N, Dalodom T, Kerr SJ, Burger DM, Ruxrungtham K,


Punyawudho B, Singkham N, Thammajaruk N, Dalodom T, Kerr SJ, Burger DM, Ruxrungtham K, (click to view)

Punyawudho B, Singkham N, Thammajaruk N, Dalodom T, Kerr SJ, Burger DM, Ruxrungtham K,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Expert review of clinical pharmacology 2016 9 23() 1-13

Abstract
INTRODUCTION
Therapeutic drug monitoring (TDM) may be beneficial when applied to antiretroviral (ARV). Even though TDM can be a valuable strategy in HIV management, its role remains controversial.

AREAS COVERED
This review provides a comprehensive update on important issues relating to TDM of ARV drugs in HIV-infected patients. Articles from PubMed with keywords relevant to each topic section were reviewed. Search strategies limited to articles published in English. Expert commentary: There is evidence supporting the use of TDM in HIV treatment. However, some limitations need to be considered. The evidence supporting the use of routine TDM for all patients is limited, as it is not clear that this strategy offers any advantages over TDM for selected indications. Selected groups of patients including patients with physiological changes, patients with drug-drug interactions or toxicity, and the elderly could potentially benefit from TDM, as optimized dosing is challenging in these populations.

Submit a Comment

Your email address will not be published. Required fields are marked *

2 × 4 =

[ HIDE/SHOW ]